C5 Inhibition in Secondary Thrombotic Microangiopathies: A Yet Unresolved Question

被引:2
|
作者
Werion, Alexis [1 ]
Rondeau, Eric [1 ]
机构
[1] Hop Tenon, AP HP, Intens Care Nephrol & Transplantat Dept, SINRA, Paris, France
来源
KIDNEY INTERNATIONAL REPORTS | 2021年 / 6卷 / 04期
关键词
COMPLEMENT INHIBITORS;
D O I
10.1016/j.ekir.2021.02.012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:878 / 880
页数:3
相关论文
共 50 条
  • [21] Discordance between Free C5 and CH50 Complement Assays in Measuring Complement C5 Inhibition in Patients with aHUS Treated with Ravulizumab
    Cataland, Spero
    Ariceta, Gema
    Chen, Peter
    Dixon, Bradley
    Garlo, Katherine
    Greenbaum, Laurence
    Rondeau, Eric
    Scully, Marie
    Ortiz, Stephan
    BLOOD, 2019, 134
  • [22] C5 DEFICIENCY IN A/J MICE IS NOT ASSOCIATED WITH RESISTANCE TO THE DEVELOPMENT OF SECONDARY AMYLOIDOSIS
    COUTINHO, M
    ZAHEDI, K
    WHITEHEAD, AS
    DAVIS, AE
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 1992, 19 (06): : 419 - 423
  • [23] A fusion protein of the two tick-derived C5 inhibitors OmCI and RaCI: complete C5 inhibition despite strong complement activation
    Erdemci-Evin, Siimeyye
    Kaupper, Verena
    Dopler, Arthur
    Dopler, Elsa
    Schmidt, Christoph Q.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 130 - 130
  • [24] Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease
    Ahmet Ozen
    Nurhan Kasap
    Ivan Vujkovic-Cvijin
    Richard Apps
    Foo Cheung
    Elif Karakoc-Aydiner
    Bilge Akkelle
    Sinan Sari
    Engin Tutar
    Figen Ozcay
    Dilara Kocacik Uygun
    Ali Islek
    Gamze Akgun
    Merve Selcuk
    Oya Balci Sezer
    Yu Zhang
    Gunsel Kutluk
    Erdem Topal
    Ersin Sayar
    Cigdem Celikel
    Roderick H. J. Houwen
    Aysen Bingol
    Ismail Ogulur
    Sevgi Bilgic Eltan
    Andrew L. Snow
    Camille Lake
    Giovanna Fantoni
    Camille Alba
    Brian Sellers
    Samuel D. Chauvin
    Clifton L. Dalgard
    Olivier Harari
    Yan G. Ni
    Ming-Dauh Wang
    Kishor Devalaraja-Narashimha
    Poorani Subramanian
    Rabia Ergelen
    Reha Artan
    Sukru Nail Guner
    Buket Dalgic
    John Tsang
    Yasmine Belkaid
    Deniz Ertem
    Safa Baris
    Michael J. Lenardo
    Nature Immunology, 2021, 22 : 128 - 139
  • [25] The effect of C5 inhibition by eculizumab on allergen-induced asthmatic responses
    Gauvreau, G.
    Boulet, L.
    Severino, B.
    Watson, R.
    Peng, T.
    Obminski, G.
    Prince, P.
    Deschesnes, F.
    Strinich, T.
    Killian, K.
    Cote, J.
    Wang, Y.
    O'Byrne, P.
    ALLERGY, 2009, 64 : 16 - 16
  • [26] C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis
    Huntemann, Niklas
    Gerischer, Lea
    Herdick, Meret
    Nelke, Christopher
    Stascheit, Frauke
    Hoffmann, Sarah
    Oeztuerk, Menekse
    Schroeter, Christina B.
    Lehnerer, Sophie
    Stein, Maike
    Schubert, Charlotte
    Schneider-Gold, Christiane
    Pfeuffer, Steffen
    Kraemer, Heidrun H.
    Konen, Franz Felix
    Skripuletz, Thomas
    Pawlitzki, Marc
    Glaubitz, Stefanie
    Zschuentzsch, Jana
    Scherwietes, Valerie
    Totzeck, Andreas
    Hagenacker, Tim
    Meuth, Sven G.
    Meisel, Andreas
    Ruck, Tobias
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2025,
  • [27] Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease
    Ozen, Ahmet
    Kasap, Nurhan
    Vujkovic-Cvijin, Ivan
    Apps, Richard
    Cheung, Foo
    Karakoc-Aydiner, Elif
    Akkelle, Bilge
    Sari, Sinan
    Tutar, Engin
    Ozcay, Figen
    Uygun, Dilara Kocacik
    Islek, Ali
    Akgun, Gamze
    Selcuk, Merve
    Sezer, Oya Balci
    Zhang, Yu
    Kutluk, Gunsel
    Topal, Erdem
    Sayar, Ersin
    Celikel, Cigdem
    Houwen, Roderick H. J.
    Bingol, Aysen
    Ogulur, Ismail
    Eltan, Sevgi Bilgic
    Snow, Andrew L.
    Lake, Camille
    Fantoni, Giovanna
    Alba, Camille
    Sellers, Brian
    Chauvin, Samuel D.
    Dalgard, Clifton L.
    Harari, Olivier
    Ni, Yan G.
    Wang, Ming-Dauh
    Devalaraja-Narashimha, Kishor
    Subramanian, Poorani
    Ergelen, Rabia
    Artan, Reha
    Guner, Sukru Nail
    Dalgic, Buket
    Tsang, John
    Belkaid, Yasmine
    Ertem, Deniz
    Baris, Safa
    Lenardo, Michael J.
    NATURE IMMUNOLOGY, 2021, 22 (02) : 128 - U24
  • [28] Complement C5 inhibition in patients with COVID-19-a promising target?
    de Latour, Regis Peffault
    Bergeron, Anne
    Lengline, Etienne
    Dupont, Thibault
    Marchal, Armance
    Galicier, Lionel
    de Castro, Nathalie
    Bondeelle, Louise
    Darmon, Michael
    Dupin, Clairelyne
    Dumas, Guillaume
    Leguen, Pierre
    Madelaine, Isabelle
    Chevret, Sylvie
    Molina, Jean-Michel
    Azoulay, Elie
    Fremeaux-Bacchi, Veronique
    HAEMATOLOGICA, 2020, 105 (12) : 2847 - 2850
  • [29] Aln-CC5, an Investigational RNAi Therapeutic Targeting C5 for Complement Inhibition
    Borodovsky, Anna
    Yucius, Kristina
    Sprague, Andrew
    Banda, Nirmal K.
    Holers, V. Michael
    Vaishnaw, Akshay
    Maier, Martin
    Kallanthottathil, Rajeev
    Charisse, Klaus
    Kuchimanchi, Satya
    Manoharan, Muthiah
    Salant, David J.
    Fitzgerald, Kevin
    Meyers, Rachel
    Sorensen, Benny
    BLOOD, 2014, 124 (21)
  • [30] INHIBITION OF C5 CONVERTASE BY EPSILON AMINOCAPROIC ACID (EACA) - LIMITING FACTOR IN GENERATION OF C5A ANAPHYLATOXIN (AT)
    VALLOTA, EH
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 1245 - 1245